US Stock MarketDetailed Quotes
TAK Takeda Pharmaceutical
- 14.950
- -0.020-0.13%
Close Aug 29 16:00 ET
- 14.900
- -0.050-0.33%
Post 20:02 ET
47.39BMarket Cap46.14P/E (TTM)
15.000High14.920Low1.02MVolume14.970Open14.970Pre Close15.33MTurnover0.03%Turnover Ratio47.61P/E (Static)3.17BShares15.73652wk High0.88P/B45.34BFloat Cap12.57552wk Low0.57Dividend TTM3.03BShs Float20.357Historical High3.82%Div YieldTTM0.53%Amplitude11.568Historical Low14.959Avg Price1Lot Size
About Takeda Pharmaceutical Company
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
Company Profile
SymbolTAK
Company NameTakeda Pharmaceutical
Listing DateDec 24, 2018
Founded1781
CEOMr. Christophe Weber
MarketNYSE
Employees49095
Securities TypeDR
ADS Ratio2.0 : 1.0
Fiscal Year Ends03-31
Address4-1-1 Dosho-machi,Chuo-Ku
CityOsaka
ProvinceOsaka
CountryJapan
Zip Code540-8645
Phone81-6-6204-2111
Websitehttp://www.takeda.com
Company Executives
- Name
- Position
- Salary
- Akiko Amakawa
- Corporate Strategy Officer and Chief Executive Officer Chief of Staff
- --
- Christophe Weber
- Director, President and Chief Executive Officer; Head of Global Business of Takeda Pharmaceuticals U.S.a., Inc.
- 1.70B
- Mwana Lugogo
- Chief Ethics and Compliance Officer
- --
- Lauren Duprey
- Chief Human Resources Officer
- --
- Gabriele Ricci
- Chief Data and Technology Officer
- --
- Milano Furuta
- Director and Chief Financial Officer
- --
- Takako Ohyabu
- Chief Global Corporate Affairs and Sustainability Officer
- --
- Dr. Thomas Wozniewski, PhD
- Global Manufacturing and Supply Officer
- --
- Elaine Shannon
- Global Quality Officer
- --
- Marcello Agosti
- Global Business Development Officer
- --
- Masami Iijima
- Chairman of the Board
- 43.00M
- Asuka Miyabashira
- President, Japan Pharma Business Unit
- --
- Andrew S. Plump, M.D.
- Director and President, Research and Development
- 12.00M
- Ramona Sequeira
- President, Global Portfolio Division
- --
- Julie Kim
- President, U.S. Business Unit and U.S. Country Head
- --
- Teresa Marie Bitetti
- President, Global Oncology Business Unit
- --
- Giles Platford
- President, Plasma-Derived Therapies Business Unit
- --
- Koji Hatsukawa
- Independent Director
- 43.00M
- Ian T. Clark
- Independent Director
- 44.00M
- Miki Tsusaka
- Independent Director
- 32.00M
- Yoshiaki Fujimori
- Independent Director
- 40.00M
- Jean-Luc Butel
- Independent Director
- 38.00M
- Dr. John M. Maraganore,PhD
- Independent Director
- 39.00M
- Michel Orsinger
- Independent Director
- 46.00M
- Emiko Higashi
- Independent Director
- 49.00M
- Dr. Steven Gillis, Pd.D
- Independent Director
- 44.00M
- Kimberly A. Reed
- Independent Director
- 41.00M
- Yoshihiro Nakagawa
- Global General Counsel
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
